Hypertension in Pregnancy and Women of Childbearing Age

American Journal of Medicine

Volumn 122, Issue 10, 2009, Pages 890-895

  Yoder, Scott R ^a   Thornburg, Loralei L ^a   Bisognano, John D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Hypertension; Preeclampsia; Pregnancy; Women

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIAZOXIDE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LABETALOL; METHYLDOPA; METOPROLOL; MINOXIDIL; NADOLOL; NIFEDIPINE; NITROPRUSSIDE SODIUM; OXPRENOLOL; PROPRANOLOL; SPIRONOLACTONE; TIMOLOL; VERAPAMIL;

BLOOD PRESSURE REGULATION; BRADYCARDIA; BREAST FEEDING EDUCATION; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTRACEPTION; DIFFERENTIAL DIAGNOSIS; DIZZINESS; EARLY DIAGNOSIS; ECLAMPSIA; EDEMA; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FETUS GROWTH; FETUS MORTALITY; FETUS RISK; GESTATIONAL AGE; HEADACHE; HUMAN; HYPOGLYCEMIA; HYPOTENSION; LIFESTYLE; LUPUS LIKE SYNDROME; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; ORTHOSTATIC HYPOTENSION; PLACENTA INSUFFICIENCY; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY COMPLICATION; PRENATAL SCREENING; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOMNOLENCE; TERATOGENICITY; TREMOR;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; ECLAMPSIA; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MATERNAL MORTALITY; MONITORING, PHYSIOLOGIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; RISK ASSESSMENT; YOUNG ADULT;

EID: 70349336417     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.03.036     Document Type: Review

References (40)

1. Chobanian A.V., Bakris G.L., Black H.R., et al., National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
2. Cunningham F.G., and Lindheimer M.D. Hypertension in pregnancy. N Engl J Med 326 (1992) 927
3. Sibai, and Baha M. Imitators of severe preeclampsia. Obstet Gynecol 109 (2007) 956-966
4. Abalos E., Duley L., Steyn D., and Henderson-Smart D. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev (2007) CD002252
5. Podymow T., and August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 51 (2008) 960-969
6. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
7. Gavard J.A., and Artal R. Effect of exercise on pregnancy outcome. Clin Obstet Gynecol 51 (2008) 467-480
8. Sorensen T.K., Williams M.A., Lee I.M., et al. Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension 41 (2003) 1273-1280
9. Saftlas A.F., Logsden-Sackett N., Wang W., et al. Work, leisure-time physical activity, and risk of preeclampsia and gestational hypertension. Am J Epidemiol 160 (2004) 758-765
10. Rudra C.B., Williams M.A., Lee I.M., et al. Perceived exertion during prepregnancy physical activity and preeclampsia risk. Med Sci Sports Exerc 37 (2005) 1836-1841
11. In: Hacker N., and Moore G. (Eds). Essentials of Obstetrics and Gynecology. 3rd edition (1998) Chapter 9
12. In: Zipes D., Libby P., Bonow R., and Braunwald E. (Eds). Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th edition (2004) Chapters 73 and 74
13. In: Murphy J., and Lloyd M. (Eds). Mayo Clinical Cardiology: Concise Textbook. 3rd edition (2007) Chapter 62
14. Helewa M.E., Burrows R.F., Smith J., et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 157 (1997) 715-725
15. Brown M.A., Hague W.M., Higgins J., et al. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol 40 (2000) 139-155
16. Briggs G.G., et al. Drugs in Pregnancy and Lactation. 4th ed. (1994), Williams & Wilkins, Baltimore 161-164
17. Smith P., Anthony J., and Johanson R. Nifedipine in pregnancy. Br J Obstet Gynaecol 107 (2000) 299-307
18. Bortolus R., Ricci E., Chatenoud L., and Parazzini F. Nifedipine administered in pregnancy: effect on the development of children at 18 months. BJOG 107 (2000) 792-794
19. Magee L.A., Elran E., Bull S.B., et al. Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 88 (2000) 15-26
20. Walker J.J. Preeclampsia. Lancet 356 (2000) 1260-1265
21. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of preeclampsia. Lancet 357 (2001) 53-56
22. Duley L., Shireen M., and Edgardo A. Management of pre-eclampsia. Br Med J 332 (2006) 463-468
23. In: Creasy R.K., Resnik R., and Iams J.D. (Eds). Creasy and Resnick's Maternal-Fetal Medicine: Principles and Practice Sixth Edition (2009), Saunders Elsevier, Philadelphia, PA
24. Brosens I.A. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol 4 (1977) 573-593
25. Roberts J.M., and Redman C.W. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341 (1993) 1447
26. Roberts J.M., Taylor R.N., Musci T.J., et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989) 1200-1204
27. Granger J.P., Alexander B.T., Llinas M.T., et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9 (2002) 147-160
28. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51 (2008) 970-975
29. Visser N., van Rijn B.B., Rijkers G.T., et al. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv 62 (2007) 191-201
30. Yang X., Ramin S.M., and Kellems R.E. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50 (2007) 269-275
31. Wallukat G., Homuth V., Fischer T., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103 (1999) 945-952
32. de Jong C.L., Dekker G.A., and Sibai B.M. The renin-angiotensin-aldosterone system in preeclampsia. A review. Clin Perinatol 18 (1991) 683-711
33. Alhenc-Gelas F., Tache A., Saint-Andre J.P., et al. The renin-angiotensin system in pregnancy and parturition. Adv Nephrol Necker Hosp 15 (1986) 25-33
34. Adams E.M., and MacGillivray I. Long-term effect of preeclampsia on blood-pressure. Lancet 2 (1961) 1373-1375
35. Sibai B.M., Mercer B., and Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 165 (1991) 1408-1412
36. Harskaqmp R.E., and Zeeman G.G. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 334 (2007) 291-295
37. Wilson B.J., Watson M.S., Prescott G.J., et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. Br Med J 326 (2003) 845-851
38. Castro M.A., Fasset M.J., Reynolds T.B., et al. Reversible peripartum liver failure: a new perspective on diagnosis, treatment and cause of acute fatty liver of pregnancy based on 28 cases. Am J Obstet Gynecol 181 (2000) 389-395
39. Briggs G.G., Freeman R.K., and Yaffe S.J. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 8th ed. (2008), Lippincott Williams & Wilkins, Baltimore
40. Schaefer C., and Peters P.W.J. Drugs During Pregnancy and Lactation. 2nd edition (2007), Academic Press